Figure 1.
Novel nephron-protective strategies in lupus nephritis. Different drugs with an anti-proteinuric effect improve renal prognosis, apart from the usual immunosuppression. GLP-1RA, Glucagon-like peptide 1 receptor agonists; SGLT-2i, Sodium-glucose cotransporter-2 inhibitor; ERAs, Endothelin receptor antagonists.